Collectively, these above‐mentioned results supported the fact that KDM3A can promote the expression of DCLK1 by removing the H3K9me2 modification and ultimately enhance the proliferation, migration and invasion of lung cancer cells. Here, DCLK1 is linked to lung carcinoma.